Breast Biopsy Market on Track for Strong Growth, Estimated to Grow at 7.2% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Breast Biopsy Market Through 2025?
The market size for breast biopsies have seen a robust growth in the preceding years. It is projected to expand from $1.42 billion in 2024 to $1.53 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.6%. The significant growth observed in the historic period has been due to various factors such as the escalating cases of breast cancer, a growing elderly population, increased awareness campaigns, rising healthcare expenses, and a swap to more convenient outpatient and ambulatory settings.

What's the Projected Size of the Global Breast Biopsy Market by 2029?
In the coming years, the market size for breast biopsies is anticipated to experience substantial growth. It's projected to expand to $2.03 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. The predicted growth during this period can be linked to improvements in healthcare infrastructure, the rise of personalized medicine, increased healthcare accessibility in emerging regions, regulatory support and reimbursement policies, as well as the emergence of telemedicine and remote diagnostics. Significant trends forecasted for this period include the incorporation of robotics into biopsy procedures, the increase in home-based biopsy kits, growing importance of genomic biopsies, a focus on patient-focused care models, the use of blockchain for data security, and the emphasis on post-biopsy monitoring tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report

Top Growth Drivers in the Breast Biopsy Industry: What's Accelerating the Market?
As the incidence of breast cancer rises, it is anticipated to stimulate the expansion of the breast biopsy market. Breast cancer, a malignant tumor that originates in the cells of the breast tissue, can metastasize to other body parts if not treated immediately. Factors such as longer life expectancy, enhanced detection techniques, and increased disease awareness contribute to the prevalence of breast cancer. A breast biopsy helps to extract tissue samples from areas in the breast that raise suspicion, enabling the diagnosis and identification of breast cancer traits. For example, the American Cancer Society, a US-based nonprofit organization, reported in January 2023 that the count of new invasive breast cancer incidents in American women increased from about 281,550 in 2021 to 297,790 in 2023. Hence, the escalating incidence of breast cancer is significantly contributing to the expansion of the breast biopsy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp

What Trends Will Shape the Breast Biopsy Market Through 2029 and Beyond?
Significant firms engaged in the breast biopsy industry are concentrating their efforts on creating cutting-edge solutions, such as vacuum-assisted breast biopsy systems, in order to provide superior treatment for patients having benign lesions. The vacuum-assisted breast biopsy method is a health device that employs suction to withdraw several tissue specimens from a potentially irregular breast zone via a solitary needle insertion. For instance, in August 2022, Devicor Medical Products, Inc., a medical device organization from the United States, introduced the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System. This system incorporates a dual vacuum technique for optimum tissue gathering, offering abundant sampling and heightened precision. It has an ergonomic design with a rotating probe for exceptional maneuverability and a single shot process to alleviate patient discomfort. Moreover, the system comes with real-time imaging integration for accurate targeting and efficient biopsy operations.

What Are the Main Segments in the Breast Biopsy Market?
The breast biopsymarket covered in this report is segmented -

1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Breast Biopsy
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications

Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp

Which Top Companies are Driving Growth in the Breast Biopsy Market?
Major companies operating in the breast biopsy market are Medtronic PLC, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), Koninklijke Philips, GE HealthCare Technologies Inc., Hologic Inc., The Cooper Companies Inc., Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc., Mermaid Medical Group, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc., Surgical Innovations Group, Sterylab Srl, Dilon Technologies Inc., INRAD Inc., Promaxo Inc.

Which Regions Will Dominate the Breast Biopsy Market Through 2029?
North America was the largest region in the breast biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19348

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.